Veracyte Income Statement (2012-2026) | VCYT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	55.10M	60.37M	67.34M	67.78M	72.86M	75.59M	80.30M	82.42M	90.32M	90.11M	98.20M	96.84M	114.43M	115.86M	118.63M	114.47M	130.16M	131.87M	140.64M	139.07M
Cost of Revenue (Quarter)	19.66M	21.67M	22.21M	23.75M	24.00M	25.68M	24.13M	26.13M	25.76M	24.34M	25.26M	23.78M	24.22M	22.61M	24.82M	24.45M	25.32M	24.45M	25.94M	27.16M
Gross Profit (Quarter)	35.44M	38.70M	45.12M	44.03M	48.86M	49.91M	56.17M	56.29M	55.82M	57.69M	64.79M	62.47M	77.91M	79.01M	78.75M	79.51M	89.77M	91.28M	101.97M	101.16M
Operating items
Amortization - Intangibles (Quarter)	3.72M	5.00M	5.50M	5.49M	5.39M	5.20M	3.17M	5.33M	4.81M	4.81M	4.04M	2.92M	2.91M	2.92M	2.81M	2.58M	2.67M	2.71M	2.71M	2.71M
Research & Development (Quarter)	6.25M	8.01M	10.25M	9.17M	9.38M	10.77M	11.29M	12.77M	12.54M	13.32M	18.67M	15.96M	16.46M	17.57M	19.29M	17.72M	16.26M	15.98M	20.85M	27.10M
Selling, General & Administrative (Quarter)	15.47M	20.75M	18.85M	20.91M	19.80M	17.60M	18.21M	21.05M	25.05M	16.33M	23.80M	26.21M	31.75M	25.74M	26.91M	33.81M	32.33M	27.28M	17.37M	23.68M
Other Operating Expenses (Quarter)	40.86M	48.30M	50.57M	52.95M	54.42M	56.90M	-64.63M	59.10M	26.28M	59.77M	57.83M	24.95M	25.10M	23.68M	28.38M	25.08M	46.44M	25.08M	26.56M	27.73M
Operating Expenses (Quarter)	62.58M	77.05M	79.67M	83.03M	83.60M	85.27M	-35.14M	92.92M	63.87M	89.43M	100.30M	67.12M	73.31M	66.99M	74.58M	76.60M	95.04M	68.34M	64.78M	78.51M
Operating Income (Quarter)	-7.47M	-16.68M	-12.33M	-15.25M	-10.73M	-9.68M	-5.42M	-10.50M	-8.05M	-31.74M	-35.51M	-4.66M	4.61M	12.02M	4.17M	2.90M	-5.27M	22.95M	37.20M	22.65M
EBIT (Quarter)	-7.47M	-16.68M	-12.33M	-15.25M	-10.73M	-9.68M	-5.42M	-10.50M	-8.05M	-31.74M	-35.51M	-4.66M	4.61M	12.02M	4.17M	2.90M	-5.27M	22.95M	37.20M	22.65M
Non-operating items
Other Non Operating Income (Quarter)	-1.72M	1.20M	1.02M	0.78M	1.09M	0.81M	1.98M	2.41M	-0.23M	1.97M	5.04M	2.75M	2.75M	4.83M	-0.73M	4.52M	6.52M	-4.06M	3.44M	7.33M
Non Operating Income (Quarter)	-1.72M	1.20M	1.02M	0.78M	1.09M	0.81M	1.98M	2.41M	-0.23M	1.97M	5.04M	2.75M	2.75M	4.83M	-0.73M	4.52M	6.52M	-4.06M	3.44M	7.33M
Net income details
EBT (Quarter)	-9.19M	-15.48M	-11.27M	-14.46M	-9.65M	-8.88M	-3.41M	-8.09M	-8.28M	-29.77M	-30.46M	-1.91M	7.36M	16.85M	3.44M	7.43M	1.25M	18.89M	40.63M	29.97M
Tax Provisions (Quarter)	-0.15M	-1.35M	-0.79M	-0.00M	-0.10M	-0.15M	0.40M		0.12M	-0.20M	-2.18M	-0.04M	1.63M	1.69M	-1.67M	0.38M	2.20M	-0.25M	-0.52M	1.30M
Profit After Tax (Quarter)	-9.04M	-14.13M	-10.53M	-14.46M	-9.53M	-8.72M	-3.84M	-8.09M	-8.40M	-29.62M	-28.29M	-1.86M	5.73M	15.15M	5.11M	7.05M	-0.98M	19.14M	41.15M	28.71M
Income from Continuing Operations (Quarter)	-9.04M	-14.13M	-10.48M	-14.46M	-9.55M	-8.72M	-3.82M	-8.09M	-8.40M	-29.57M	-28.28M	-1.86M	5.73M	15.15M	5.11M	7.05M	-0.95M	19.14M	41.15M	28.67M
Consolidated Net Income (Quarter)	-9.04M	-14.13M	-10.48M	-14.46M	-9.55M	-8.72M	-3.82M	-8.09M	-8.40M	-29.57M	-28.28M	-1.86M	5.73M	15.15M	5.11M	7.05M	-0.95M	19.14M	41.15M	28.67M
Income towards Parent Company (Quarter)	-9.04M	-14.13M	-10.48M	-14.46M	-9.55M	-8.72M	-3.82M	-8.09M	-8.40M	-29.57M	-28.28M	-1.86M	5.73M	15.15M	5.11M	7.05M	-0.95M	19.14M	41.15M	28.67M
Net Income towards Common Stockholders (Quarter)	-9.04M	-14.13M	-10.48M	-14.46M	-9.55M	-8.72M	-3.82M	-8.09M	-8.40M	-29.57M	-28.28M	-1.86M	5.73M	15.15M	5.11M	7.05M	-0.95M	19.14M	41.15M	28.67M
Additional items
EPS (Basic) (Quarter)	-0.13	-0.20	-0.14	-0.20	-0.13	-0.12	-0.05	-0.11	-0.12	-0.41	-0.38	-0.02	0.07	0.20	0.07	0.09	-0.01	0.24	0.52	0.36
EPS (Weighted Average and Diluted) (Quarter)	-0.13	-0.20	-0.14	-0.20	-0.13	-0.12	-0.05	-0.11	-0.12	-0.41	-0.38	-0.02	0.07	0.19	0.06	0.09	-0.01	0.24	0.50	0.35
Shares Outstanding (Weighted Average) (Quarter)	67.32M	66.82M	67.89M	71.23M	71.35M	71.66M	71.55M	72.18M	72.33M	72.81M	72.64M	74.76M	76.54M	77.01M	76.48M	78.03M	78.21M	78.38M	78.58M	79.54M
Shares Outstanding (Diluted Average) (Quarter)	67.32M	66.82M	67.89M	71.23M	71.35M	71.66M	71.55M	72.18M	72.48M	72.49M	72.64M	74.76M	77.16M	78.46M	78.16M	80.06M	78.39M	79.95M	80.57M	81.31M
EBITDA (Quarter)	-9.04M	-16.68M	-12.33M	-15.25M	-10.73M	-9.68M	-5.42M	-10.50M	-8.05M	-31.74M	-35.51M	-4.66M	4.61M	12.02M	4.17M	2.90M	-5.27M	22.95M	37.20M	22.65M
Interest Expenses (Quarter)	0.06M
Tax Rate (Quarter)	1.65%	8.72%	6.98%	0.02%	1.04%	1.71%	-11.80%		-1.51%	0.67%	7.15%	2.31%	22.10%	10.05%	-48.50%	5.13%	176.00%	-1.31%	-1.27%	4.34%

Research Tools

Veracyte Income Statement (2012-2026) | VCYT

Create an account

Sign In

Reset Password